Koers Chongqing Lummy Pharmaceutical Co., Ltd.
Aandelen
300006
CNE100000H10
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,76 CNY | +2,60% | +4,55% | -25,81% |
Omzet 2022 | 885 mln. 122 mln. 114 mln. | Omzet 2023 | 896 mln. 124 mln. 116 mln. | Marktkapitalisatie | 3,93 mld. 542 mln. 507 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -68 mln. -9,38 mln. -8,78 mln. | Nettowinst (verlies) 2023 | -8 mln. -1,1 mln. -1,03 mln. | EV/omzet 2022 | 4 x |
Nettoliquiditeiten 2022 | 481 mln. 66,39 mln. 62,09 mln. | Nettoliquiditeiten 2023 | 566 mln. 78,06 mln. 73,01 mln. | EV/omzet 2023 | 3,75 x |
K/w-verhouding 2022 |
-58,5
x | K/w-verhouding 2023 |
-438
x | Werknemers | 800 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 32,5% |
1 dag | +2,60% | ||
1 week | +4,55% | ||
Lopende maand | -10,39% | ||
1 maand | -9,80% | ||
3 maanden | -18,58% | ||
6 maanden | -26,79% | ||
Lopend jaar | -25,81% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Rong Zhao Qiu
CEO | Chief Executive Officer | 30 | 12-06-20 |
Wen Lai
DFI | Director of Finance/CFO | 50 | 01-01-03 |
Yuan Yuan
CHM | Chairman | 42 | 01-02-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Xue Feng Leng
BRD | Director/Board Member | 52 | - |
Zhang Bi Li
BRD | Director/Board Member | 52 | 13-07-20 |
Hui Chuan Xu
CTO | Chief Tech/Sci/R&D Officer | 46 | 01-01-07 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 2,76 | +2,60% | 17 879 130 |
25-04-24 | 2,69 | 0,00% | 12 511 650 |
24-04-24 | 2,69 | -0,37% | 16 618 000 |
23-04-24 | 2,7 | +1,50% | 13 208 100 |
22-04-24 | 2,66 | +0,76% | 10 131 450 |
slotkoers Shenzhen S.E., 26 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-25,81% | 402 mln. | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |